Deletion of M2 Gene Open Reading Frames 1 and 2 of Human Metapneumovirus: Effects on RNA Synthesis, Attenuation, and Immunogenicity
Overview
Authors
Affiliations
The M2 gene of human metapneumovirus (HMPV) contains two overlapping open reading frames (ORFs), M2-1 and M2-2. The expression of separate M2-1 and M2-2 proteins from these ORFs was confirmed, and recombinant HMPVs were recovered in which expression of M2-1 and M2-2 was ablated individually or together [rdeltaM2-1, rdeltaM2-2, and rdeltaM2(1+2)]. Each M2 mutant virus directed efficient multicycle growth in Vero cells. The ability to recover HMPV lacking M2-1 contrasts with human respiratory syncytial virus, for which M2-1 is an essential transcription factor. Expression of the downstream HMPV M2-2 ORF was not reduced when translation of the upstream M2-1 ORF was silenced, indicating that it is initiated separately. The rdeltaM2-2 mutants exhibited a two- to fivefold increase in the accumulation of mRNA, normalized to the genome template, suggesting that M2-2 has a role in regulating RNA synthesis. Replication and immunogenicity were tested in hamsters. Animals infected intranasally with rdeltaM2-1 or rdeltaM2(1+2) did not have recoverable virus in the lungs or nasal turbinates on days 3 or 5 postinfection and did not develop HMPV-neutralizing serum antibodies or resistance to HMPV challenge. Thus, M2-1 appears to be essential for significant virus replication in vivo. In animals infected with rdeltaM2-2, virus was recovered from only 1 of 12 animals and only in the nasal turbinates on a single day. However, all of the animals developed a high titer of HMPV-neutralizing serum antibodies and were highly protected against challenge with wild-type HMPV. The HMPV rdeltaM2-2 virus is a promising and highly attenuated HMPV vaccine candidate.
Ribo-Molina P, Groen K, Susma B, van Nieuwkoop S, Funk M, Fouchier R J Virol. 2025; 99(2):e0124324.
PMID: 39835813 PMC: 11852930. DOI: 10.1128/jvi.01243-24.
Guo J, Shi Y, Jiang G, Zeng P, Wu Z, Wang D J Virol. 2024; 98(4):e0005124.
PMID: 38466095 PMC: 11019959. DOI: 10.1128/jvi.00051-24.
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus.
Ma S, Zhu F, Xu Y, Wen H, Rao M, Zhang P Hum Vaccin Immunother. 2024; 19(3):2293300.
PMID: 38172569 PMC: 10824151. DOI: 10.1080/21645515.2023.2293300.
Visentin A, Demitroff N, Salgueiro M, Borkosky S, Uversky V, Camporeale G Viruses. 2023; 15(6).
PMID: 37376628 PMC: 10303025. DOI: 10.3390/v15061329.
Cross-protective antibodies against common endemic respiratory viruses.
Caban M, Rodarte J, Bibby M, Gray M, Taylor J, Pancera M Nat Commun. 2023; 14(1):798.
PMID: 36781872 PMC: 9923667. DOI: 10.1038/s41467-023-36459-3.